Literature DB >> 3339142

Acyclovir for recurrent erythema multiforme caused by herpes simplex.

J C Huff1.   

Abstract

Herpes-associated erythema multiforme can be controlled by continuous suppressive treatment with oral acyclovir. Erythema multiforme is not prevented if oral acyclovir is administered after a herpes simplex recurrence is evident and it is of no value after erythema multiforme has occurred. There is some question whether continuous topical treatment with acyclovir to sites of recurrent herpes will sometimes prevent erythema multiforme. Erythema multiforme may be precipitated by orolabial and genital recurrences and by recurrences on skin of the buttocks and other sites. Some herpetic recurrences are associated with erythema multiforme and some are not and episodes of erythema multiforme are not always associated with clinical herpetic recurrences.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3339142     DOI: 10.1016/s0190-9622(88)70027-4

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

1.  Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017.

Authors:  John R Su; Penina Haber; Carmen S Ng; Paige L Marquez; Graça M Dores; Silvia Perez-Vilar; Maria V Cano
Journal:  Vaccine       Date:  2019-12-20       Impact factor: 3.641

2.  Chlamydia pneumoniae infection-associated erythema multiforme.

Authors:  Shinsaku Imashuku; Naoko Kudo
Journal:  Pediatr Rep       Date:  2013-06-13

3.  Immune-mediated interface dermatitis in a rhesus macaque.

Authors:  L Makaron; K Smith; C Bailey; S Kaliyaperumal; A Miller; J Kramer
Journal:  J Med Primatol       Date:  2012-08-10       Impact factor: 0.667

Review 4.  Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  J J O'Brien; D M Campoli-Richards
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

Review 5.  Long-term valacyclovir treatment and immune modulation for Herpes-associated erythema multiforme.

Authors:  Jurate Staikuniene; Jurate Staneviciute
Journal:  Cent Eur J Immunol       Date:  2015-10-15       Impact factor: 2.085

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.